PMID- 15765807 OWN - NLM STAT- MEDLINE DCOM- 20050419 LR - 20220228 IS - 1355-0284 (Print) IS - 1355-0284 (Linking) VI - 10 IP - 6 DP - 2004 Dec TI - Human T-cell leukemia virus type I Tax induces the expression of dendritic cell markers associated with maturation and activation. PG - 358-71 AB - Human T-cell leukemia virus type I (HTLV-I) is the etiologic agent of both adult T-cell leukemia (ATL) and HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Although the genesis of HAM/TSP likely involves several steps, the generation of a highly specific and effective population of Tax-specific CD8+ cytotoxic T lymphocytes (CTLs) that migrate to the central nervous system (CNS) is of pivotal importance in this neuropathologic process. Presentation of Tax peptides by activated dendritic cells (DCs) to naive CD8+ T cells likely plays an important role in the induction of a Tax-specific CTL response and the eventual neurologic dysfunction observed in HAM/TSP. The immune response mounted during HTLV-I infection is primarily targeted against Tax with both Tax-specific antibodies and CTLs found in HTLV-I-infected individuals, indicating that Tax is available for immune recognition. Studies have suggested that Tax may be secreted from HTLV-I-infected cells and act as an extracellular cytokine, be internalized and processed for presentation, or be transported to the nucleus where it may act as a transcriptional activator. The authors report in this article that purified Tax induces DC activation involving an increase in the production of CD80 and CD86 mRNA in the absence of corresponding protein synthesis. Furthermore, intracellular Tax down-regulates the protein expression of molecules involved in antigen presentation. This implies a difference in the mechanism of Tax activity depending upon its location. Additionally, treatment of JAWS II DCs with extracellular Tax decreases the ability of DCs to present a major histocompatibility complex (MHC) class I-restricted peptide, indicating that Tax likely matures the DCs to the point where presentation of a secondary antigen is restricted. The implication of the experimental results with respect to the generation of a Tax-specific CTL compartment that participates in the genesis of HAM/TSP is discussed. FAU - Mostoller, Kate AU - Mostoller K AD - Department of Microbiology and Immunology, The Pennsylvania State University, College of Medicine, Hershey, Pennsylvania, USA FAU - Norbury, Christopher C AU - Norbury CC FAU - Jain, Pooja AU - Jain P FAU - Wigdahl, Brian AU - Wigdahl B LA - eng GR - AI056094/AI/NIAID NIH HHS/United States GR - CA54559/CA/NCI NIH HHS/United States GR - NS044801-01/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Neurovirol JT - Journal of neurovirology JID - 9508123 RN - 0 (Antigens, CD) RN - 0 (B7-1 Antigen) RN - 0 (B7-2 Antigen) RN - 0 (Biomarkers) RN - 0 (CD40 Antigens) RN - 0 (CD86 protein, human) RN - 0 (Gene Products, tax) RN - 0 (Histocompatibility Antigens Class I) RN - 0 (Membrane Glycoproteins) RN - 0 (RNA, Messenger) SB - IM MH - Animals MH - Antigen Presentation MH - Antigens, CD/drug effects/metabolism MH - B7-1 Antigen/drug effects/metabolism MH - B7-2 Antigen MH - Biomarkers MH - CD40 Antigens/drug effects/metabolism MH - Cell Differentiation/*drug effects/physiology MH - Dendritic Cells/*drug effects/metabolism/*virology MH - Dose-Response Relationship, Drug MH - Flow Cytometry MH - Gene Expression Profiling MH - Gene Expression Regulation MH - Gene Products, tax/metabolism/*pharmacology MH - HTLV-I Infections/*physiopathology MH - Histocompatibility Antigens Class I MH - Human T-lymphotropic virus 1/metabolism MH - Humans MH - Membrane Glycoproteins/drug effects/metabolism MH - Oligonucleotide Array Sequence Analysis MH - RNA, Messenger MH - Reverse Transcriptase Polymerase Chain Reaction MH - Time Factors EDAT- 2005/03/16 09:00 MHDA- 2005/04/20 09:00 CRDT- 2005/03/16 09:00 PHST- 2005/03/16 09:00 [pubmed] PHST- 2005/04/20 09:00 [medline] PHST- 2005/03/16 09:00 [entrez] AID - 10.1080/13550280490521104 [doi] PST - ppublish SO - J Neurovirol. 2004 Dec;10(6):358-71. doi: 10.1080/13550280490521104.